WASHINGTON– An Indiana based pharmaceutical company is working with the Trump Administration to better serve seniors enrolled in Medicare.

Speaking from the White House yesterday, Eli Lilly and Company CEO David Ricks says they’ve worked hard to lower drug prices, especially insulin.

President Trump signed an executive order cracking down on medical fraud and surprise billing. It also capped insulin prices to 35-dollars a month and under some plans, insulin would be free. Eli Lilly has also been looking at creating new medicine, by studying the antibodies from surviving patients in the United States and turning their antibodies into a medicine.